L.T. Smith
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 2
- Genetics 3
- Genomic variations and chromosomal abnormalities 2
- Co-authors
- Maode Wang (2 shared papers)Ping Mao (2 shared papers)Kaushal Joshi (1 shared paper)Peipei Li (1 shared paper)Ichiro Nakano (1 shared paper)Panayiotis V. Benos (1 shared paper)Robert W. Sobol (1 shared paper)Sung-Hak Kim (1 shared paper)
- Journals
- Separation Science and Technology (2 papers)Engineering Construction & Architectural Management (1 paper)Frontiers in Public Health (1 paper)Oncogene (1 paper)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
L.T. Smith
22 papers receiving 974 citations
L.T. Smith's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 270
- Genetics 189
- Oncology 202
- Molecular Biology 420
- Hematology 62
Countries citing papers authored by L.T. Smith
This map shows the geographic impact of L.T. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.T. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.T. Smith more than expected).
Fields of papers citing papers by L.T. Smith
This network shows the impact of papers produced by L.T. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.T. Smith. The network helps show where L.T. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside L.T. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 Hit paper breakdown → | 2013 | 518 |
| 2 | 1996 | 122 | |
| 3 | 2007 | 91 | |
| 4 | 2005 | 50 | |
| 5 | 2006 | 33 | |
| 6 | 2013 | 32 | |
| 7 | 2010 | 22 | |
| 8 | 1984 | 16 | |
| 9 | 2012 | 16 | |
| 10 | 2013 | 15 | |
| 11 | 2022 | 13 | |
| 12 | 1979 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2008 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2001 | 2 | |
| 19 | Modeling of Pilot-Scale Salt-cake Dissolution | 2006 | 2 |
| 20 | 2022 | 1 |
About L.T. Smith
L.T. Smith is a scholar working on Molecular Biology, Genetics, Cancer Research, Civil and Structural Engineering and Genetics, having authored 23 papers that have together received 989 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Clay minerals and soil interactions (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cancer Genomics and Diagnostics (1 paper) and Sustainable Building Design and Assessment (1 paper). The work is most often cited by research in Cancer Research (270 citations), Genetics (189 citations), Oncology (202 citations), Molecular Biology (420 citations) and Hematology (62 citations). L.T. Smith has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Maode Wang, Ping Mao, Kaushal Joshi, Peipei Li, Ichiro Nakano, Panayiotis V. Benos, Robert W. Sobol, Sung-Hak Kim, Shi‐Yuan Cheng and Uma Chandran. Their work appears in journals such as Separation Science and Technology, Engineering Construction & Architectural Management, Frontiers in Public Health, Oncogene and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.